A practical guide to the management of menopausal symptoms in breast cancer patients

Supportive Care in Cancer

Volumn 13, Issue 8, 2005, Pages 573-578

  Gainford, M C ^a   Simmons, C ^a   Nguyen, H ^b   Verma, S ^a   Clemons, M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANGELICA SINENSIS EXTRACT; ANTICONVULSIVE AGENT; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; FLUOXETINE; GABAPENTIN; MEDROXYPROGESTERONE; MEGESTROL ACETATE; PAROXETINE; PRIMROSE OIL; PROGESTERONE; PYRIDOXINE; RALOXIFENE; RED CLOVER EXTRACT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TIBOLONE; VENLAFAXINE;

ALTERNATIVE MEDICINE; ANGELICA SINENSIS; APPETITE DISORDER; BONE DENSITY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; FRACTURE REDUCTION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; NAUSEA; NONHUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; RED CLOVER; REVIEW; SEX ROLE; SEXUAL FUNCTION; SOMNOLENCE; SOYBEAN; UROGENITAL TRACT DISEASE; XEROSTOMIA;

BREAST NEOPLASMS; CANADA; COMPLEMENTARY THERAPIES; FEMALE; GUIDELINES; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS; PATIENT CARE; UROGENITAL SYSTEM;

EID: 22844452447     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0847-y     Document Type: Review

References (32)

1. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321-333
2. Shumaker SA, Legault C, Rapp SR et al (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
3. The Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial. JAMA 291:1701-1712
4. Holmberg L, Anderson H, for the HABITS Steering and Data Monitoring Committees (2004) HABITS (Hormonal Replacement Therapy After Breast Cancer - is it safe?), a randomized comparison: trial stopped. Lancet 363:453-455
5. Ganz PA, Greendale GA, Peterson L et al (2000) Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 92:1054-1064
6. Loprinzi CL, Michalak JC, Quella SK et al (1994) Megestrol acetate for the prevention of hot flashes. N Engl J Med 331:347-352
7. Quella SK, Loprinzi CL, Sloan JA et al (1998) Long-term use of megestrol acetate for treatment of hot flashes in cancer survivors. Cancer 82:1784-1788
8. Eden J (2003) Progestins and breast cancer. Am J Obstet Gynecol 188:1123-1131
9. Million Women Study Collaborators (2003) Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362:419-427
10. Modelska K, Cummins S (2002) Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 87:16-23
11. Loprinzi CL, Kugler JW, Sloan JA et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 356:2059-2063
12. Barton D, La VB, Loprinzi C et al (2002) Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 29:33-40
13. Loprinzi CL, Sloan JA, Perez E et al (2002) Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20(6):1578-1583
14. Stearns V, Beebe KL, Iyengar M et al (2003) Paroxetine controlled release in the treatment of menopausal hot flashes - a randomized controlled trial. JAMA 289:2827-2834
15. Pandya KJ, Thummala AR, Griggs JJ et al (2004) Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat 83:87-89
16. Struble E, Dice Y, Ornstein DL et al (2004) Gabapentin versus venlafaxine for the treatment of menopausal symptoms: a preliminary report. Breast Cancer Res Treat 88(Suppl 1):240-241 (abstract# 6061)
17. Goldberg RM, Loprinzi CL, O'Fallon JR et al (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 12:155-158
18. Pandya KJ, Raubertas RF, Flynn PJ et al (2000) Oral clonidine in post-menopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Ann Intern Med 132:788-793
19. Barton DL, Loprinzi CL, Quella SK et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495-500
20. Miller ER, Pastor-Barriuso R, Dalal D et al (2005) Meta-analysis: high dose vitamin E supplementation may increase all cause mortality. Ann Intern Med 142:37-46
21. Kessel B, Kronenberg F (2004) The role of complimentary and alternative medicine in management of menopausal symptoms. Endocrinol Metab Clin N Am 33:717-739
22. Quella SK, Loprinzi CL, Barton D et al (2000) Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol 18:1068-1074
23. Van Patten CL, Olivotto IO, Chambers GK et al (2002) Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized controlled clinical trial. J Clin Oncol 20:1449-1455
24. Jacobson JS, Troxel AB, Evans J et al (2001) Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19:2739-2745
25. Kurzer M (2003) Phytoestrogen supplement use by women. J Nutr 133:1983s-1986s
26. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936
27. Hillner BE, Ingle JN, Chlebowski R et al (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21:4042-4057
28. Fleisch H (2003) Bisphosphonates in osteoporosis. Eur Spine J 12:S142-S146
29. Kerarnopopoullos A, Gaki V, Baltas D et al (2003) Stopping tamoxifen after 5 years. What's next? Breast 12:S40-S41 (Abstract P92)
30. The ATAC Trialists' Group (2003) Anastrazole alone or in combination with tamoxifen vs tamoxifen alone for adjuvant treatment of postmenopausal women with early stage breast cancer. Results Of the ATAC trial efficacy and safety update analysis. Cancer 98:1802-1810
31. Bachmann GA, Leiblum SR (2004) The impact of hormones on menopausal sexuality: a literature review. Menopause 11:120-130
32. Somboonporn W, Davis S (2004) Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25:374-388